# Gentian Diagnostics ASA (GENT.OL): MoatMap facts

As of 17 Oct 2026. Research data, not investment advice.

As of 17 Oct 2026, MoatMap's StockRank for Gentian Diagnostics ASA (GENT.OL) is 65/100, ranked against 24,000+ stocks in 35 markets (Quality 73, Value 42, Momentum 45, each scored against its sector).

- StockRank: 65/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 73, Value 42, Momentum 45: each a 0-100 percentile within the stock's sector.
- Position: #9,321 overall, #927 in Healthcare.
- Listing: Norway, OSL; Healthcare / Medical Devices.
- Last close: 37.5 NOK on 15 Oct 2026.
- Insider filings, last 180 days: directors bought USD 19K.

Source: https://moatmap.ai/stock/GENT.OL
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker